Peng Liang

Co-Founder, President & Chairman at Clover Biopharmaceuticals

Inventor of Trimer-Tag© technology

Co-inventor of Differential Display technology

Discovered IL-24 and its receptors (licensed to Wyeth)

Winner of 1998 Molecular Bioanalytics Prize from the German Society of Biological Chemistry & Molecular Biology

Published 80+ original research papers in peer-reviewed journals including SCIENCE, with over 10,000 Citations

Former Associate Professor of Cancer Biology, Vanderbilt University

Postdoc, Harvard Medical School under Dr. Arthur Pardee

PhD in Biochemistry, University of Illinois

BS in Biology, Beijing UniversityInventor of Trimer-Tag© technology

Co-inventor of Differential Display technology

Discovered IL-24 and its receptors (licensed to Wyeth)

Winner of 1998 Molecular Bioanalytics Prize from the German Society of Biological Chemistry & Molecular Biology

Published 80+ original research papers in peer-reviewed journals including SCIENCE, with over 10,000 Citations

Former Associate Professor of Cancer Biology, Vanderbilt University

Postdoc, Harvard Medical School under Dr. Arthur Pardee

PhD in Biochemistry, University of Illinois

BS in Biology, Beijing University

Location

Nashville, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Clover Biopharmaceuticals

2 followers

Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases.


Industries

Headquarters

Chengdu, China

Employees

501-1,000

Links